Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT)

Am J Cardiol. 2002 Jun 15;89(12):1414-6. doi: 10.1016/s0002-9149(02)02357-3.
No abstract available

MeSH terms

  • Amlodipine / therapeutic use*
  • Calcium Channel Blockers / therapeutic use*
  • Coronary Angiography
  • Coronary Artery Disease / prevention & control*
  • Coronary Disease / drug therapy*
  • Coronary Restenosis
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Calcium Channel Blockers
  • Amlodipine